Cargando…
Folding Molecular Dynamics Simulation of a gp41-Derived Peptide Reconcile Divergent Structure Determinations
[Image: see text] T-20 peptide is the first FDA-approved fusion inhibitor against AIDS/HIV-1 gp41 protein. Part of it, the gp41[659–671] peptide, that contains the complete epitope for the neutralizing 2F5 monoclonal antibody, has been found experimentally in a number of divergent structures. Herein...
Autores principales: | Georgoulia, Panagiota S., Glykos, Nicholas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643504/ https://www.ncbi.nlm.nih.gov/pubmed/31458149 http://dx.doi.org/10.1021/acsomega.8b01579 |
Ejemplares similares
-
Order through Disorder: Hyper-Mobile C-Terminal Residues Stabilize the Folded State of a Helical Peptide. A Molecular Dynamics Study
por: Patapati, Kalliopi K., et al.
Publicado: (2010) -
Prediction of Protein–Protein Binding Interactions in Dimeric Coiled Coils by Information Contained in Folding Energy Landscapes
por: Georgoulia, Panagiota S., et al.
Publicado: (2021) -
Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
por: Pu, Jing, et al.
Publicado: (2019) -
Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope
por: Penn-Nicholson, Adam, et al.
Publicado: (2008) -
A molecular dynamics simulation study on the propensity of Asn-Gly-containing heptapeptides towards β-turn structures: Comparison with ab initio quantum mechanical calculations
por: Mitsikas, Dimitrios A., et al.
Publicado: (2020)